Old Web
English
Sign In
Acemap
>
authorDetail
>
Philipp D. LeCoutre
Philipp D. LeCoutre
Charité
Medicine
Nilotinib
Internal medicine
Imatinib
Cohort
4
Papers
44
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Nilotinib in chronic myeloid leukemia patients in chronic phase (CML-CP) with imatinib (IM) resistance or intolerance: Longer follow-up results of a phase II study
2016
Journal of Clinical Oncology
H. Kantarjian
F. Giles
Kapil Bhalla
Javier Pinilla
R. A. Larson
Norbert Gattermann
O. Ottmann
Neil Gallagher
M. Baccarani
Philipp D. LeCoutre
Show All
Source
Cite
Save
Citations (20)
Nilotinib Versus Imatinib in Patients (pts) with Newly Diagnosed Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leukemia in Chronic Phase (CML-CP): ENESTnd 36-Month (mo) Follow-up
2011
Blood
Giuseppe Saglio
Philipp D. LeCoutre
Ricardo Pasquini
Saengsuree Jootar
Hirohisa Nakamae
Ian W. Flinn
Andreas Hochhaus
Timothy P. Hughes
Richard A. Larson
Albert Hoenekopp
Neil Gallagher
Richard Yu
Rick E. Blakesley
Dong-Wook Kim
Hagop M. Kantarjian
Show All
Source
Cite
Save
Citations (17)
Retrospective Cohort Analysis of Peripheral Arterial Occlusive Disease (PAOD) Events in Patients (pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
2011
Blood
Francis J. Giles
Michael J. Mauro
Frank Hong
Christine-Elke Ortmann
Richard C. Woodman
Philipp D. LeCoutre
Giuseppe Saglio
Show All
Source
Cite
Save
Citations (6)
Significance of ELN Provisional Response Definitions In Predicting Long-Term Outcomes of Patients with CP-CML Treated with Dasatinib After Imatinib Failure.
2010
Blood
Jorge E. Cortes
Neil P. Shah
Charles A. Schiffer
Philipp D. LeCoutre
Giuseppe Saglio
Alfonso Quintás-Cardama
Hagop M. Kantarjian
Elias Jabbour
Erkut Bahceci
Allen C. Chen
Alexandre Lambert
François Guilhot
Show All
Source
Cite
Save
Citations (1)
1